Medpace Holdings (MEDP) Return on Capital Employed (2016 - 2026)

Medpace Holdings (MEDP) has reported Return on Capital Employed for 11 consecutive years, with 79.56% the latest figure, recorded in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 79.56%, up 2752.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 79.56% (up 2752.0% YoY), and the FY2025 annual result was 77.03%, up 1932.0% from the prior year.
• Return on Capital Employed was 79.56% for Q1 2026 at Medpace Holdings, down from 102.77% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 133.99% in Q3 2025 and troughed at 23.32% in Q1 2022.
• Average Return on Capital Employed over 5 years is 61.36%, with a median of 52.04% recorded in 2025.
• Year-over-year, Return on Capital Employed slumped 1501 bps in 2024 and soared 9143 bps in 2025.
• Over 5 years, Return on Capital Employed stood at 51.9% in 2022, then rose by 0 bps to 52.09% in 2023, then declined by 13 bps to 45.23% in 2024, then jumped by 127 bps to 102.77% in 2025, then decreased by 23 bps to 79.56% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 79.56% in Q1 2026, 102.77% in Q4 2025, and 133.99% in Q3 2025.